Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Clinical trial NCT00390429 · COMPLETED
Trial details
- NCT number
- NCT00390429
- Sponsor
- University of California, Davis
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2008-08-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.